logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Schools 'freedom' to exclude pupils comes with a heavy caveat

25 November 2010

The Government’s white paper has set out plans to pilot a new approach to permanent exclusions. Under the plans, schools will be free to exclude pupils but will then be responsible for finding and funding alternative provision themselves. The Government suggests that schools could collaborate with other schools to provide suitable places or buy them from the local authority, voluntary sector or local colleges.

If the responsibility for finding and funding alterative provision is not enough of a disincentive for schools to exclude pupils, schools will also be held accountable by retaining excluded pupils’ ongoing academic performance in their performance tables.

The government is keen to discourage schools from shifting problem pupils on to someone else’s turf and incentivise schools to ensure pupils get good alternative provision. Head teachers, local authorities and the government will begin working together soon to test the new approach.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up